Conversely, the ICC defines strong expression as occurring when any part of the neoplastic blast population reaches the intensity level of CD19 seen in stage 1 B-cell progenitors (also shown in Figure 2b) or mature B cells [2]. The gene discussed is CD19; the disease is intrahepatic cholangiocarcinoma.